It was discovered in a screen for monoclonal antibodies that reversed the macrophage-resistant phenotype of tumor cells, making them more sensitive to killing by macrophage-elaborated tumor necrosis factor-alpha (TNF-α) [6]. Here, TNF is linked to neoplasm.